BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35045478)

  • 1. [A Case of Cholangiocellular Carcinoma in Lynch Syndrome Treated by an Immune Checkpoint Inhibitor].
    Shinke G; Takeda Y; Ohmura Y; Katsura Y; Haruna K; Kihara Y; Kusafuka H; Sakaue M; Katsuyama S; Kawai K; Hiraki M; Masuzawa T; Takeno A; Hata T; Murata K
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):2014-2016. PubMed ID: 35045478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite Instability-high Intrahepatic Cholangiocarcinoma with Portal Vein Tumor Thrombosis Successfully Treated with Pembrolizumab.
    Naganuma A; Sakuda T; Murakami T; Aihara K; Watanuki Y; Suzuki Y; Shibasaki E; Masuda T; Uehara S; Yasuoka H; Hoshino T; Kudo T; Ishihara H; Ogawa T; Kitamoto Y; Ogawa A
    Intern Med; 2020 Sep; 59(18):2261-2267. PubMed ID: 32536644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of pembrolizumab in microsatellite instability-high locally advanced cholangiocarcinoma: a case report.
    Toshida K; Itoh S; Yoshizumi T; Shimagaki T; Wang H; Kurihara T; Toshima T; Nagao Y; Harada N; Oki E; Nakamura Y; Yoshino T; Mori M
    Clin J Gastroenterol; 2021 Oct; 14(5):1459-1463. PubMed ID: 34085164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation.
    T Danley K; Schmitz K; Ghai R; Sclamberg JS; Buckingham LE; Burgess K; Kuzel TM; Usha L
    Oncologist; 2021 Oct; 26(10):811-817. PubMed ID: 34018286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rechallenge With Switching Immune Checkpoint Inhibitors Following Autoimmune Myocarditis in a Patient With Lynch Syndrome.
    Eslinger C; Walden D; Barry T; Shah S; Samadder NJ; Bekaii-Saab TS
    J Natl Compr Canc Netw; 2023 Sep; 21(9):894-899. PubMed ID: 37673116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection of metachronous bile duct cancer in Lynch syndrome: report of a case.
    Shigeyasu K; Tanakaya K; Nagasaka T; Aoki H; Fujiwara T; Sugano K; Ishikawa H; Yoshida T; Moriya Y; Furukawa Y; Goel A; Takeuchi H
    Surg Today; 2014 Oct; 44(10):1975-81. PubMed ID: 23896635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cholangiocellular cancer: the state of the problem and ways to improve the results of surgical treatment].
    Patyutko YI; Polyakov AN; Podluzhnyi DV; Syskova AY; Sagaidak IV; Kotel'nikov AG; Sergeeva ON; Pokataev IA
    Khirurgiia (Mosk); 2018; (12):30-37. PubMed ID: 30560842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive tumor microenvironment in occupational cholangiocarcinoma: Supportive evidence for the efficacy of immune checkpoint inhibitor therapy.
    Sato Y; Tanaka S; Kinoshita M; Takemura S; Shinkawa H; Kokudo T; Hasegawa K; Tanaka H; Yoshimoto H; Mori A; Yamamura M; Sasaki M; Harada K; Kubo S
    J Hepatobiliary Pancreat Sci; 2020 Nov; 27(11):860-869. PubMed ID: 32506715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Case Report of an Elderly Patient's Intrahepatic Cholangiocellular Carcinoma with Cholangitis].
    Ito H; Ochiai T; Nakatsuji H; Inoue H; Watanabe N; Yoshiyama A; Toma A; Nakamura K; Otsuji E
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1823-1825. PubMed ID: 29394788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of successful management of advanced cholangiocellular carcinoma by repeated hepatic resection].
    Nakano H; Sasaki Y; Imaoka S; Furukawa H; Ishikawa O; Kabuto T; Kameyama M; Hiratsuka M; Ohigashi H; Nakamori S; Yasuda T; Iwanaga T
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1603-6. PubMed ID: 8854817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and Treatment of MSI-H Cancer in Gynecological Cancer].
    Yamamoto N; Tashiro H; Katabuchi H
    Gan To Kagaku Ryoho; 2018 Nov; 45(11):1577-1581. PubMed ID: 30449841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholangiocarcinoma producing parathyroid hormone-related peptide treated with chemoradiation using gemcitabine and S-1.
    Yamada M; Shiroeda H; Shiroeda S; Sato K; Arisawa T; Tsutsumi M
    Intern Med; 2009; 48(24):2097-100. PubMed ID: 20009399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case of bile duct carcinoma of the hepatic hilus with segmental obstructive cholangitis.
    Sakamoto E; Nimura Y; Hayakawa N; Kamiya J; Kondo S; Nagino M; Kanai M; Miyachi M; Kawabata Y
    Hepatogastroenterology; 1995; 42(5):501-5. PubMed ID: 8751205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Successful treatment for advanced cholangiocellular carcinoma with intrahepatic metastasis and/or portal vein tumor thrombi by intraarterial chemotherapy combined with 5-fluorouracil, adriamycin and cisplatin (FAP)--two cases report].
    Wada H; Nagano H; Dono K; Kondo M; Yamamoto T; Ota H; Nakamura M; Yoshioka S; Damdinsuren B; Yubo Y; Marubashi S; Miyamoto A; Umeshita K; Nakamori S; Sakon M; Monden M
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1711-3. PubMed ID: 15553691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Immune Checkpoint Inhibitors in the Treatment of Cholangiocarcinoma.
    Zeng FL; Chen JF
    Technol Cancer Res Treat; 2021; 20():15330338211039952. PubMed ID: 34528830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent biliary dissemination of colon cancer liver metastasis: a case report.
    Onishi I; Kayahara M; Takei R; Makita N; Munemoto M; Yagi Y; Kawashima A
    J Med Case Rep; 2018 Oct; 12(1):314. PubMed ID: 30367665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of unresectable cholangiocellular carcinoma treated with surgery followed by combination chemotherapy].
    Hayashi N; Hasuike Y; Fukuchi N; Kida H; Tujie M; Yoshida T; Ebisui C; Sakita I; Koshino T; Izumiyama K; Koro T; Fujimoto T
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1852-4. PubMed ID: 16315961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lynch syndrome-associated epithelial ovarian cancer and its immunological profile.
    Rasmussen M; Lim K; Rambech E; Andersen MH; Svane IM; Andersen O; Jensen LH; Nilbert M; Therkildsen C
    Gynecol Oncol; 2021 Sep; 162(3):686-693. PubMed ID: 34275654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer.
    Rizell M; Andersson M; Cahlin C; Hafström L; Olausson M; Lindnér P
    Int J Clin Oncol; 2008 Feb; 13(1):66-70. PubMed ID: 18307022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of low-dose irinotecan for multiple lung metastases of cholangiocellular carcinoma after operation--a case report].
    Kutomi G; Katsuramaki T; Mukaiya M; Hirata K; Shimodan M; Adachi H
    Gan To Kagaku Ryoho; 2002 May; 29(5):781-4. PubMed ID: 12040685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.